header imageimage mobile


developing the next evolution in degradation platforms.

image about mobile
about image

Our autophagy-targeting chimeric small molecule platform degrades targets by exploiting the cellular mechanism of autophagy, a phenomenon found
in every cell.

From cancer, to inflammation, to the central nervous system, our platform attacks hard-to-drug targets wherever we find them.

Working on
a hard-to-drug


Autophagy is one of the best studied phenomena of the cell. It is responsible for destroying proteins, mitochondria, and other cellular debris, and is one of the many natural defence systems against viruses and bacteria.